Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jstrokecerebrovasdis.2020.105061 http://scihub22266oqcxt.onion/10.1016/j.jstrokecerebrovasdis.2020.105061 C7305910!7305910 !32807466     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32807466 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       J+Stroke+Cerebrovasc+Dis 2020 ; 29 (9 ): 105061 Nephropedia Template TP {{tp|p=32807466 |t=2020. Universal laboratory testing for SARS-CoV-2 in hyperacute stroke during the COVID-19 pandemic |pdf=|usr=}}{{32807466 }} gab.com Text Universal laboratory testing for SARS-CoV-2 in hyperacute stroke during the COVID-19 pandemic JO: J Stroke Cerebrovasc Dis http://www.kidney.de/pget.php?&tw=1&pmid=32807466 #FOAvip OBJECTIVE: Stroke patients are thought to be at increased risk of Coronavirus Disease 2019 (COVID-19). To evaluate yield of universal laboratory testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in acute stroke patients and its impact on hyperacute stroke care. METHODS: Between weeks 14 and 18 in 2020, a protected code stroke protocol including infection control screening and laboratory testing for SARS-CoV-2 was prospectively implemented for all code stroke patients upon arrival to the emergency department. If infection control screen was positive, patients received protective hygienic measures and laboratory test results were available within four hours from testing. In patients with negative screen, laboratory results were available no later than the next working day. Door-to-imaging times of patients treated with thrombolysis or thrombectomy were compared with those of patients treated during the preceding weeks 1 to 13 in 2020. RESULTS: During the 4-weeks study period, 116 consecutive code stroke patients underwent infection control screen and laboratory testing for SARS-CoV-2. Among 5 (4.3%) patients whose infection control screen was positive, no patient was tested positive for SARS-CoV-2. All patients with negative infection control screens had negative test results. Door-to-imaging times of patients treated with thrombolysis and/or thrombectomy were not different to those treated during the preceding weeks (12 [9-15] min versus 13 [11-17] min, p?=?0.24). CONCLUSIONS: Universal laboratory testing for SARS-CoV-2 provided useful information on patients' infection status and its implementation into a protected code stroke protocol did not adversely affect hyperacute stroke care. Twit Text FOAVip Universal laboratory testing for SARS-CoV-2 in hyperacute stroke during the COVID-19 pandemic ????J Stroke Cerebrovasc Dis http://www.kidney.de/pget.php?&tw=1&pmid=32807466 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32807466 #FOAvip English Wikipedia <ref>{{Cite pmid|32807466 }}</ref> Universal laboratory testing for SARS-CoV-2 in hyperacute stroke during the COVID-19 pandemic #MMPMID32807466 Barlinn K ; Siepmann T ; Pallesen LP ; Winzer S ; Sedghi A ; Schroettner P ; Hochauf-Stange K ; Prakapenia A ; Moustafa H ; de With K ; Linn J ; Reichmann H ; Barlinn J ; Puetz V J Stroke Cerebrovasc Dis 2020[Sep]; 29 (9 ): 105061 PMID32807466 show ga OBJECTIVE: Stroke patients are thought to be at increased risk of Coronavirus Disease 2019 (COVID-19). To evaluate yield of universal laboratory testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in acute stroke patients and its impact on hyperacute stroke care. METHODS: Between weeks 14 and 18 in 2020, a protected code stroke protocol including infection control screening and laboratory testing for SARS-CoV-2 was prospectively implemented for all code stroke patients upon arrival to the emergency department. If infection control screen was positive, patients received protective hygienic measures and laboratory test results were available within four hours from testing. In patients with negative screen, laboratory results were available no later than the next working day. Door-to-imaging times of patients treated with thrombolysis or thrombectomy were compared with those of patients treated during the preceding weeks 1 to 13 in 2020. RESULTS: During the 4-weeks study period, 116 consecutive code stroke patients underwent infection control screen and laboratory testing for SARS-CoV-2. Among 5 (4.3%) patients whose infection control screen was positive, no patient was tested positive for SARS-CoV-2. All patients with negative infection control screens had negative test results. Door-to-imaging times of patients treated with thrombolysis and/or thrombectomy were not different to those treated during the preceding weeks (12 [9-15] min versus 13 [11-17] min, p?=?0.24). CONCLUSIONS: Universal laboratory testing for SARS-CoV-2 provided useful information on patients' infection status and its implementation into a protected code stroke protocol did not adversely affect hyperacute stroke care. |*Clinical Laboratory Techniques [MESH] |Aged [MESH] |Aged, 80 and over [MESH] |Betacoronavirus/*isolation & purification [MESH] |COVID-19 [MESH] |COVID-19 Testing [MESH] |Clinical Decision-Making [MESH] |Coronavirus Infections/complications/*diagnosis/therapy/virology [MESH] |Emergency Service, Hospital [MESH] |Female [MESH] |Humans [MESH] |Infection Control [MESH] |Male [MESH] |Pandemics [MESH] |Patient Safety [MESH] |Patient Selection [MESH] |Pneumonia, Viral/complications/*diagnosis/therapy/virology [MESH] |Predictive Value of Tests [MESH] |Prospective Studies [MESH] |Risk Factors [MESH] |SARS-CoV-2 [MESH]Universal laboratory testing for SARS-CoV-2 in hyperacute stroke durin(epmc).pdf DeepDyve Pubget Overpricing